No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
68 |
4. Check minimum number of eventsNone |
68 |
5. Include endpointsNone |
68 |
6. Filter based on genotype QC (FinnGen only) |
65 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Similar endpoints
↥List of similar endpoints to
Supernumerary ureter
based on the number of shared cases.
Similar with more cases:
- Congenital obstructive defects of renal pelvis and congenital malformations of ureter
- Congenital malformations of the urinary system
- Congenital malformations of the urinary system
- Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly
- Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 65 | 56 | 9 |
| Unadjusted period prevalence (%) | 0.02 | 0.02 | 0.00 |
| Median age at first event (years) | 18.03 | 13.99 | 43.13 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 68
- Matched controls
- 680
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Q62.5
ICD-10 Finland
Duplication of ureter
+∞
97.7
68
*
UKC02
NOMESCO Finland
Cystoscopy
16.9
30.0
33
36
J01EA01
ATC
trimethoprim; systemic
5.9
12.3
37
114
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
7.3
12.0
22
42
Q62.7
ICD-10 Finland
Congenital vesico-uretero-renal reflux
129.1
10.7
11
*
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
15.7
10.6
17
14
1530
FHL
Urethrocystoscopy
57.7
8.9
10
*
KBH20
NOMESCO Finland
Replantation of ureter
76.8
6.5
7
*
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
4.2
6.0
20
62
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
34
164
3.15
5.10
5.1
3.6
—
—
—
0
0
18
70
3.14
3.75
3.3
3.3
3.51
3.31
e6/l
0.04
12
43
17
69
2.95
3.27
3.1
3.1
0.61
0.73
e6/l
0.10
11
42
7
14
5.44
2.80
1.3
1.4
—
—
—
0
0
7
16
4.75
2.55
1.3
1.3
—
—
—
0
0
25
154
1.99
1.85
2.0
1.8
93.58
97.89
pmol/l
0.19
14
76
26
169
1.87
1.61
8.0
10.2
1.12
1.15
inr
—
9
53
29
197
1.82
1.56
10.9
8.2
1.23
1.22
mmol/l
0.42
29
180
36
265
1.76
1.46
4.6
3.7
0.00
0.00
estimate
—
9
55
10
49
2.22
1.29
1.2
1.7
—
—
—
0
0
35
263
1.68
1.27
6.3
4.8
0.00
0.00
estimate
—
8
55
24
163
1.73
1.25
4.4
3.6
26.25
27.55
u/l
0.19
24
155
6
26
2.43
1.21
1.3
1.4
—
—
—
0
0
35
268
1.63
1.15
4.5
3.6
0.00
0.00
estimate
—
9
59
12
67
1.96
1.13
1.8
1.8
—
—
—
0
0
19
127
1.69
1.03
2.5
3.2
17.90
19.72
ng/l
—
10
70
0
32
0.00
0.98
0.0
1.1
—
4.57
—
0
23
8
43
1.97
0.91
2.3
15.4
24.29
25.22
mmol/l
—
8
43
8
47
1.79
0.84
1.3
1.7
—
—
—
0
0
52
460
1.55
0.76
13.0
8.0
89.53
96.43
ml/min/173m2
0.81
40
344
7
40
1.83
0.74
3.6
4.5
35.29
32.88
%
—
7
26
34
279
1.44
0.71
2.3
2.5
—
—
—
0
0
17
122
1.52
0.69
1.8
1.7
1.57
1.15
mmol/l
0.59
17
108
42
363
1.41
0.63
8.4
6.0
91.74
82.76
u/l
0.21
42
335
10
64
1.66
0.62
7.4
2.4
2.42
2.59
g/l
—
10
59
8
52
1.61
0.62
1.3
1.5
—
—
—
0
0
8
52
1.61
0.62
1.3
1.5
—
—
—
0
0
8
52
1.61
0.62
1.3
1.5
—
—
—
0
0
17
125
1.48
0.61
1.7
2.2
—
—
—
0
0
6
36
1.73
0.58
4.7
4.6
3.25
8.69
ug/l
—
6
29
6
36
1.73
0.58
2.2
1.3
—
—
—
0
0
57
531
1.45
0.46
19.5
13.8
13.85
13.91
%
0.04
57
526
8
57
1.46
0.44
1.4
1.6
—
—
—
0
0
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
11
80
1.45
0.41
6.8
3.0
11.60
31.18
ng/l
—
5
40
0
17
0.00
0.41
0.0
1.2
—
—
—
0
0
5
36
1.42
0.39
2.8
10.7
103.80
104.42
mmol/l
—
5
36
59
564
1.35
0.30
14.9
10.7
24.91
18.62
mg/l
0.68
46
407
8
66
1.24
0.28
2.3
6.5
29.88
29.30
s
—
8
66
13
105
1.29
0.27
1.5
1.9
—
—
—
0
0
11
87
1.32
0.26
1.3
1.7
—
—
—
0
0
5
42
1.21
0.22
12.2
6.0
-0.14
1.49
mmol/l
—
5
35
0
11
0.00
0.21
0.0
1.3
—
2.00
—
0
6
0
10
0.00
0.21
0.0
1.0
—
3.59
—
0
10
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
0.00
—
0
10
0
10
0.00
0.21
0.0
1.0
—
8.01
—
0
10
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
3.12
—
0
10
0
10
0.00
0.21
0.0
1.0
—
37.36
—
0
10
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
0.00
—
0
10
0
10
0.00
0.21
0.0
1.0
—
0.00
—
0
10
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
9.69
—
0
10
0
10
0.00
0.21
0.0
1.0
—
0.00
—
0
10
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
6
52
1.17
0.19
2.0
1.7
—
—
—
0
0
7
60
1.19
0.18
1.7
1.7
829.41
1097.34
nmol/l
—
7
46
18
160
1.17
0.16
1.4
2.4
—
—
—
0
0
12
104
1.19
0.13
4.3
3.7
292.17
300.70
umol/l
0.16
12
97
5
48
1.04
0.09
5.0
5.0
—
—
—
0
0
14
154
0.89
0.09
6.4
3.9
0.00
0.00
estimate
—
8
53
5
62
0.79
0.08
1.0
1.0
—
—
—
0
0
35
337
1.08
0.06
7.7
9.3
3.81
4.00
e9/l
0.28
30
293
18
173
1.06
0.01
1.6
2.6
—
—
—
0
0
48
473
1.05
0.01
4.8
3.4
1.48
1.54
mmol/l
0.42
48
443
21
211
0.99
0.00
5.6
3.4
—
—
—
0
0
50
503
0.98
0.00
4.3
4.0
—
—
—
0
0
10
104
0.95
0.00
1.2
1.5
—
—
—
0
0
14
144
0.97
0.00
1.3
1.5
—
—
—
0
0
48
482
0.99
0.00
5.2
3.6
2.65
2.72
mmol/l
0.28
48
454
22
218
1.01
0.00
1.4
2.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.8
—
—
—
0
0
5
59
0.84
-0.00
2.0
1.4
—
—
—
0
0
7
76
0.91
-0.00
2.0
2.1
1.59
1.27
%
—
7
70
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.9
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
4.0
—
159.10
—
0
7
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
13.49
—
0
7
0
7
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
111.43
—
0
7
0
6
0.00
-0.00
0.0
2.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
98.00
—
0
5
0
5
0.00
-0.00
0.0
2.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.2
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: Q17_SUPERNUMERARY_URETER – Supernumerary ureter
GWS hits: -
This endpoint is excluded (different definition than used in FinnGen).